| Fund ID | 805-3938482185 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 13% |
| Owned by funds of funds | 25% |
| Owned by non-U.S. persons | 43% |
| Fund | Type | Gross assets |
|---|---|---|
| Clarus Iv-C, L.P. | Venture Capital | $304.1M |
| Clarus Iv-A, L.P. | Venture Capital | $255.9M |
| Clarus Iv-B, L.P. | Venture Capital | $164.8M |
Clarus Lifesciences II, L.P. reports $49.7 million in gross assets, among the top 54% of private funds by size.
The stated minimum investment is $5 million.
Clarus Lifesciences II, L.P. is managed by Clarus Ventures, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.